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Three different prenyltransferases attach isoprenyl anchors to C-terminal motifs in substrate proteins. These lipid
anchors serve for membrane attachment or protein–protein interactions in many pathways. Although well-tolerated
selective prenyltransferase inhibitors are clinically available, their mode of action remains unclear since the known
substrate sets of the various prenyltransferases are incomplete. The Prenylation Prediction Suite (PrePS) has been
applied for large-scale predictions of prenylated proteins. To prioritize targets for experimental verification, we rank
the predictions by their functional importance estimated by evolutionary conservation of the prenylation motifs within
protein families. The ranked lists of predictions are accessible as PRENbase (http://mendel.imp.univie.ac.at/sat/PrePS/
PRENbase) and can be queried for verification status, type of modifying enzymes (anchor type), and taxonomic
distribution. Our results highlight a large group of plant metal-binding chaperones as well as several newly predicted
proteins involved in ubiquitin-mediated protein degradation, enriching the known functional repertoire of prenylated
proteins. Furthermore, we identify two possibly prenylated proteins in Mimivirus. The section HumanPRENbase
provides complete lists of predicted prenylated human proteins—for example, the list of farnesyltransferase targets
that cannot become substrates of geranylgeranyltransferase 1 and, therefore, are especially affected by
farnesyltransferase inhibitors (FTIs) used in cancer and anti-parasite therapy. We report direct experimental evidence
verifying the prediction of the human proteins Prickle1, Prickle2, the BRO1 domain–containing FLJ32421 (termed
BROFTI), and Rab28 (short isoform) as exclusive farnesyltransferase targets. We introduce PRENbase, a database of
large-scale predictions of protein prenylation substrates ranked by evolutionary conservation of the motif.
Experimental evidence is presented for the selective farnesylation of targets with an evolutionary conserved
modification site.
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Introduction
Protein prenylation is facilitated by three eukaryotic
enzymes with partially overlapping substrate speciﬁcities
[1–3]. Farnesyltransferase (FT) and geranylgeranyltransferase
I (GGT1) recognize the so-called C-terminal CaaX box of
substrate proteins to attach either a farnesyl (15 carbons) or
geranylgeranyl (20 carbons) anchor to the conserved
cysteine via a thioether linkage. Rab geranylgeranyltransfer-
ase or geranylgeranyltransferase II (GGT2) requires the
formation of a complex of the substrate protein with a
dedicated escort protein, REP (Rab escort protein) [4], and
typically attaches two geranylgeranyl anchors to C-terminal
cysteines in motifs such as -XXXCC, -XXCXC, -XXCCX,
-XCCXX, or -CCXXX [5]. Isoprenyl lipid anchor attachment
to C-termini of proteins not only serves for membrane
targeting but can also be crucial for protein–protein
interactions [6]. Inhibition of protein prenylation is a
promising approach for developing anti-cancer drugs [7] as
well as for treating parasitic diseases [8,9]. Therefore, it is of
great scientiﬁc and applied medical interest to clarify which
proteins and pathways are affected by farnesyl- or geranyl-
geranyltransferase inhibitors in human cells or in unicellular
parasites.
Based on the reﬁnement of descriptions of sequence
motifs recognized by the three enzymes (FT, GGT1, and
GGT2) in substrate proteins, we have recently developed
amino acid sequence–based predictors for various types of
protein prenylation (PrePS [10]). PrePS is available as a
WWW service (http://mendel.imp.ac.at/sat/PrePS/index2.
html). Since the rate of false-positive predictions of PrePS
is low (for proteins with CXXX C-terminus, the false-positive
rate is estimated at ;5% at a sensitivity for true targets of
;98% [10]), this tool is appropriate for large-scale auto-
mated annotation (for example, for proteome scans). In this
work, we apply PrePS to ﬁnding all potential protein
substrates of the three prenyltransferases. With the analyses
of these protein sets, it can be determined which prenylation
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As previous experience with a similar project (the
application of the MyrPS/NMT myristoylation predictor
[11,12] for searching the nonredundant database and the
resulting MYRbase [13]) has shown, large-scale scans produce
a considerable number of hits, and, for their ranking with
respect to the biological signiﬁcance, additional criteria are
necessary. It should be noted that the score function of PrePS
tests the concordance of C-termini of query proteins (the
terminal 12 residues) with a simpliﬁed binding site model of
the respective prenyltransferase without consideration of
other sequence properties. It is not rare that sites for
posttranslational modiﬁcations and sequence motifs coding
for subcellular translocation are not conserved among
proteins with otherwise highly similar sequences (exemplary
cases of myristoylation [13], GPI lipid anchoring [14], and
prenylation [15]). More surprisingly, functional motifs can be
hidden in proteins without the proper biological context and
be masked by other sequence signals (e.g., the case of
peroxisomal targeting signal type 1 (PTS1) in proteins
destined for other subcellular localizations [16]). Never-
theless, conservation of the prenylation site among a larger
number of homologues will indicate enhanced biological
importance of the potential lipid modiﬁcation and increase
the conﬁdence in correct prediction (evOluation concept in
MYRbase [13]). Therefore, evolutionary conservation of
prenylation sites in homologous families can be used for
ranking in hit lists and for the selection of potential targets
for experimental veriﬁcation in conditions of limited
resources.
Here, we report the results obtained after applying the
three prenylation predictors over the National Center for
Biotechnology Institute’s (NCBI) nonredundant protein
sequence database (NR). The proteins predicted to be
prenylated have been clustered into homologous families
and are made available as the annotated database PRENbase.
A sophisticated interface can generate target lists with
regard to the experimental status of the modiﬁcation
( k n o w n ,p r e d i c t e d ,e t c . ) ,e xclusive or shared types of
modifying enzymes (FT, GGT1, GGT2), as well as for
evolutionary conservation by constraining the taxonomic
distribution within clusters or for single sequences. We
investigate the validity of various hit-ranking schemes
relying on sequence homology information and taxonomic
distribution. Finally, we use PRENbase to list human
proteins that could represent elusive cellular targets of FT
inhibitors (lack of alternative prenylation by GGT1 under
FT inhibition) [17] and verify experimentally the prenylation
status of selected human proteins (versions of Rab28, the
BRO1/rhophilin domain containing FLJ32421 [termed
BROFTI], Prickle1, and Prickle2) following our published
protocols [18].
PRENbase: Methodological Workflow and Database
Description
The three predictors included in PrePS [10] have been run
over the NR at NCBI. After removing protein fragments with
an incomplete C-terminus (as annotated in Genbank), 5,410
proteins were predicted to be prenylated. Figure 1 shows the
distribution among the three modifying enzymes, including
their substrate protein overlaps. While the number of
predicted substrates shared between FT and GGT1 is not
surprising (mainly due to the fact that FT can also prenylate
substrates with terminal leucine [10]), it is interesting that
there also is a substantial overlap with GGT2. At least for
Rab8 and Rab11, this enzyme ambiguity has been demon-
strated in vitro [19,20]. It has to be mentioned that the
predictions by PrePS merely represent the capability of a
substrate sequence to be modiﬁed when presented to the
enzyme. In vivo, activity, relative afﬁnity, and availability of
FT, GGT1, and GGT2 in the cellular context determine which
enzyme will execute the prenylation for a given substrate
protein.
Family clustering. To facilitate the selection of targets for
experimental validation, we tried to rank the predictions by
Author Summary
Various cellular functions require reversible membrane localization
of proteins. This is often facilitated by attaching lipids to the
respective proteins, thus anchoring them to the membrane. For
example, addition of prenyl lipid anchors (prenylation) is directed by
a motif in the protein sequence that can be predicted using a
recently developed method. We describe the prediction of protein
prenylation in all currently known proteins. The annotated results
are available as an online database: PRENbase. A ranking of the
predictions is introduced, assuming that existence of a prenylation
sequence motif in related proteins from different species (evolu-
tionary conservation) relates to functional importance of the lipid
anchor. We present experimental evidence for high-ranked human
proteins predicted to be affected by anticancer drugs inhibiting
prenylation.
Figure 1. Distribution of Predicted Substrate Proteins among the Three
Prenyltransferases
doi:10.1371/journal.pcbi.0030066.g001
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PRENbasethe importance of the lipid anchor for their function based
on the analysis of evolutionary motif conservation within
protein families. It would be of special interest to study the
conservation of farnesyl, geranylgeranyl, and double gera-
nylgeranyl anchors within protein families, as this can
indicate exclusive or overlapping substrate speciﬁcity be-
tween the three enzymes. Thus, the extent of variation can
give additional hints on the importance of the speciﬁc anchor
size [8]. We employed BLAST [21] and the MCL (Markov
chain clustering) algorithm [22] to assign the 5,410 predicted
sequences to a total of 1,024 clusters (protein families). For
details on the clustering procedure, see the Materials and
Methods section.
Annotation of families of predicted homologous prenyla-
tion targets. We have manually curated protein family
annotations for clusters with at least three sequences (201
clusters total). Due to the power law–like behavior of protein
family cluster sizes [13], we could provide curated cluster
annotation for approximately 83% of the predicted sequen-
ces by looking at only 20% of all clusters. The remaining
clusters of size 1 or 2 have been annotated with names
automatically extracted from their description lines.
In addition to the protein family name and function
description, we annotated clusters with respect to veriﬁcation
status. This is not a trivial task because it requires manual
lookup of hundreds of literature sources. While the actual
number of experimentally veriﬁed proteins is small com-
pared with the total number of predictions, many proteins
can safely be assumed to be prenylated simply by similarity to
known examples. We annotate clusters/families as KNOWN
(þ) when they include at least one from a list of 113 proteins
experimentally veriﬁed to be prenylated. In addition, we
created the annotation category LIKELY (*) for clusters that
do not have an experimentally veriﬁed example included
directly, but where members of the cluster show a clear
similarity (BLAST E-value , 1e 10) to at least one of the
veriﬁed cases. Finally, clusters without any detectable
similarity to any of the 113 proteins experimentally veriﬁed
to be prenylated are categorized in PRENbase as NEW (?).
While the former families (with annotation KNOWN and
LIKELY) form a basis to summarize existing knowledge of
prenylated proteins, the latter (NEW) are of special interest
because their function apparently has not been recognized
yet in the context of prenylation.
During the annotation process, we have also encountered
a few predictions where conservation of a C-terminal
cysteine in CaaX box arrangement can also occur for
prenylation-independent functions such as disulﬁde bridges
(e.g., metridin-like ShK toxin family members). Although
these do not appear to be prenylation targets in vivo, it
cannot be excluded that they become prenylated in a
different context when their C-termini would be exposed to
the prenylating enzyme. The endothelin-converting enzyme
1 (ECE1) from the neprilysin-like zinc metallopeptidase
family is another example with a CaaX box where the
capacity for prenylation is apparently not used in vivo
(possibly because of a disulﬁde bond). It is predicted by
PrePS to be weakly prenylated and, indeed, its C-terminus
has been shown to be weakly prenylatable in vitro [15].
However, it is known to be a type II transmembrane protein.
Therefore, the C-terminus and, hence, the potential pre-
nylation motif moves to the lumenal side of the endoplasmic
reticulum membrane and becomes inaccessible for the
prenyltransferases. In agreement with the cellular context,
the protein does not appear to be prenylated in vivo [15,23].
Thus, these predictions are not necessarily false positives.
We have annotated these predictions in PRENbase as OUT-
OF-CONTEXT ( ).
Family ranking. If a predicted protein feature, such as a
prenylated C-terminus, is conserved among a large number of
homologues (large cluster size), this feature appears more
critical for biological function and more reliably predicted.
Thus, predictions can be scored by
Sclustersize ¼ Nph; ð1Þ
where Nph is the number of family members with a predicted
prenylation site. However, the number of homologous
proteins sharing the motif becomes less indicative for ranking
purposes when the protein family in general is overrepre-
sented in nature or in the databases, respectively (e.g.,
immunoglobulin chains). Hence, knowledge of the total
family size, including proteins with and without the inves-
tigated motif, can be used to balance for such overrepre-
sentation. As suggested earlier [24], ranking of families by
evolutionary motif conservation could be performed with a
scoring function such as
SevOluation ¼
N2
ph
Nth
; ð2Þ
where Nph is the number of predicted and Nth is the total
number of homologues or family members. This ratio
balances for overrepresented sequences when compared with
the simple ranking by cluster size (Equation 1). The square of
Nph also helps to downrank very small clusters or orphans
relative to clusters with large Nph; e.g., Nph as well as Nth is 1 in
these cases.
Instead of ranking based on counting the number of
homologues, it is also possible to analyze the taxonomic
distribution and score the families according to how wide-
spread (or old) the motif is in the evolution of the protein
family. Such phylogenic complexity can simply be estimated
as a score function of the number of species (Nspec) that have
family members with the motif. To remove artiﬁcial bias
introduced through disproportional sequencing coverage of
speciﬁc proteins of closely related species, we suggest multi-
plying Nspec by a factor that evaluates the broad distribution
throughout all kingdoms and selected divisions. In our case,
we count how many of 12 selected taxonomic groups from all
kingdoms (archaea, bacteria, viruses, mammals, birds, am-
phibiae, ﬁshes, insects, nematodes, fungi, plants, and ‘‘other
eukaryotes’’) are covered by the investigated family (N12  
12). Then, the ﬁnal phylogenic complexity scoring function
can be written as:
Sphylocomplex ¼
N12
12
  Nspec ð3Þ
It should be noted that ranking based on phylogenic
complexity does not require the computationally costly
determination of the total family size (including members
without the motif). Large clusters that consist mainly of
sequences of closely related species are downranked in favor
of families with a more widespread taxonomic distribution.
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PRENbaseTo investigate the performance of the different ranking
schemes, we plotted the distribution of clusters colored by
their annotated modiﬁcation status (Figure 2). Clusters that
are homologous to proteins that have already been shown
experimentally to be prenylated are shown in green. Those
without known prenylated homologues are colored blue (or
yellow if the cluster size is smaller than three). Clusters where
the motif appears conserved for prenylation-independent
functions are colored red. The median values for the
distribution of the different cluster and ranking types are
marked in Figure 2 and listed in Table 1.
It can be seen that the simple ranking by cluster size brings
the known or likely prenylated proteins (green clusters) to the
front of the list. However, the red clusters also appear to be
highly ranked. Using the evOluation score [13] for ranking
retains the green in front and moves the red to the back. The
phylogenic complexity approach performs somewhat worse
in downranking the red clusters, but, in contrast, it keeps
larger unknown clusters (blue) closer to the top of the list. In
conclusion, the different ranking schemes substantially
inﬂuence the distribution of clusters and might be used to
select targets based on emphasis of speciﬁcity of the motif for
the complete protein family (evOluation [13]) or on taxo-
nomic diversity (phylogenic complexity).
Estimate of gain of performance when adding evOluation
to PrePS. We previously estimated that PrePS misses about
2% of yet unknown prenylation motifs (cross-validated
average sensitivity of PrePS: 98%) while predicting only
0.1% false positives in complete database searches (average
speciﬁcity of PrePS: 99.9%) [10]. This estimate for false
positive predictions includes motifs that can be prenylated in
vitro, while the in vivo context makes the lipid modiﬁcation
rather unlikely. In this work, we identiﬁed and discussed such
examples (see the previous subsection Annotation of families
of predicted homologous prenylation targets). We referred to
these predictions as OUT-OF-CONTEXT rather than as false
positives. Since there are no new cutoffs and the ‘‘evOlua-
tion’’ score is only used for a priority ranking of all
predictions, the absolute rates of false negative and false
positive predictions in PRENbase are by deﬁnition the same
as those reported for the PrePS method. We do, however,
show that the evOluation score widens the gap between true
positives (KNOWN) and contextual false positives OUT-OF-
CONTEXT in the ranking. This is visualized in Figure 2,
quantiﬁed in Table 1, and further discussed in the previous
paragraphs.
To estimate the performance gain of adding the evOlua-
tion ranking compared with the standard PrePS prediction
alone, we apply ROC analysis by sliding an artiﬁcial threshold
over the cluster ranks and count the true positive (KNOWN)
and contextual false positive (OUT-OF-CONTEXT) clusters
above or below the given thresholds. This allows plotting
sensitivity (100-rate of false negatives) versus speciﬁcity (100-
rate of false positives) for the different methods (Figure 3). As
Table 1. Values of Cluster Medians from Figure 2
Number Size EvOluation Phylogenic Complexity
88 0.10 0.07 0.16
203 0.11 0.42 0.11
1058 0.59 0.56 0.58
21 0.15 0.57 0.23
doi:10.1371/journal.pcbi.0030066.t001
Figure 3. Performance Gain of Ranking Schemes over Standard PrePS
without Ranking
doi:10.1371/journal.pcbi.0030066.g003
Figure 2. Performance of Different Ranking Schemes for Clusters with Predicted Prenylation Targets
doi:10.1371/journal.pcbi.0030066.g002
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PRENbasecan be seen, the evOluation score clearly outperforms the
other ranking schemes and results in a gain in contextual
speciﬁcity of up to 60% at high sensitivities compared with
the standard PrePS. Apparently, random occurrences of small
motifs, a typical source of false positives, are indicated by a
lower conservation within their protein family, and this
feature can therefore be used to further reduce false positives
in the context of the biological importance of the motif for
the protein. We propose that similarly signiﬁcant perform-
ance gains could also be reached for other methods
predicting small sequence motifs by considering the evolu-
tionary conservation of the predicted motifs within protein
families.
PRENbase Web interface. The manually annotated clusters/
families of prenylated proteins described above are available
as PRENbase. A Web interface (Figure 4, http://mendel.imp.
univie.ac.at/sat/PrePS/PRENbase/) has been designed to allow
sophisticated queries to PRENbase: (1) for the experimental
status of the modiﬁcation (KNOWN/LIKELY/NEW/OUT-OF-
CONTEXT); (2) for the range of prenyltransferasesexclusive
Figure 4. Screenshot of PRENbase Query Interface
doi:10.1371/journal.pcbi.0030066.g004
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PRENbaseor shared types of modifying enzymes (FT, GGT1, GGT2); as
well as (3) for evolutionary conservation by constraining the
taxonomic distribution within clusters or for single sequen-
ces. The output can be ranked by cluster size, by the
evOluation score that also takes into account the total family
size in databases, or by an estimated phylogenic complexity.
The default settings give access to the collection of both
known and predicted eukaryotic and viral prenylated
proteins, which can then be browsed. To facilitate tasks for
less-experienced users, we have listed a series of standard
queries that might be of particular biological interest.
Queries are assigned to a unique query code that can be
used to recover previous queries without having to readjust
the multiple parameters of the interface. Furthermore, users
can map their own sequence against PRENbase using a
BLAST module linked to the PrePS server (http://mendel.imp.
univie.ac.at/sat/PrePS/).
HumanPRENbase. For biomedical applications, it is of
great interest to know which human proteins are particularly
affected by prenyltransferase inhibitors that have already
passed phase II and III clinical trials [25] but whose molecular
mode of action is not fully understood yet [2]. For example,
farnesyltransferase (FT) inhibitors can abolish the prenyl
modiﬁcation only for substrates that cannot be alternatively
modiﬁed by GGT1 (Figure 5). The classical examples are (1)
H-Ras that can only be modiﬁed by FT (hereafter, proteins of
this type are called pF) and (2) K-Ras that can be a substrate
of both FT and GGT1 (hereafter, pFGG). The distinction of
pF- and pFGG-type proteins is critical since it helps to
identify the exclusive cellular targets affected by FT inhib-
ition (pFs) and give hints to the molecular mechanisms
involved in various cancer types [2,17].
The most prominent group of prenylated oncogenes
comprises members of the Ras superfamily of small GTPases.
InPRENbase,theseareclusteredtogetherinasmallnumberof
large families with high SevOluation (Equation 2) and Sphylocomplex
(Equation 3). This example shows that it is useful to clearly
identify the orthologous counterparts of individual human
proteins. A procedure to derive clusters of such orthologous
groups is described in detail in the Materials and Methods
section and has allowed the creation of a list of 242 unique
human clusters with their isoforms and in-paralogues merged
together in the same cluster with at least one (human) member
predicted to be prenylated. We removed sequences that are
less than 50% of the length of the query sequence (in cases of
multidomain proteins) to avoid ambiguous cluster assign-
ments of short homologous sequences. Furthermore, the
resulting clusters made up by the orthologues and a repre-
sentative human sequence are available in a style similar to the
original PRENbase. The listed status annotation is derived
using the same criteria as for the general PRENbase clusters.
For example, there are few members of the large Ras, Rab, and
RhofamiliesofGTPaseswheretheprenylationhasbeenshown
directly (annotated as KNOWN). However, for many other
related clusters (annotated as LIKELY), prenylation can often
be safely inferred if a valid motif exists. On the other hand,
clusters annotated as NEW signify that this protein family is
notyet known tobe prenylated andcould involve a completely
new mode of action for prenyltransferase inhibitors. This
HumanPRENbase (http://mendel.imp.univie.ac.at/sat/PrePS/
HumanPRENbase/) can now be queried for the experimental
status of the modiﬁcation of homologues (known/new...), and
exclusive or shared types of modifying enzymes (FT, GGT1,
GGT2)aswellasforevolutionaryconservationbyconstraining
the taxonomic distribution within clusters or for single
sequences. The output can also be ranked by cluster size, by
evOluation, score or by phylogenic complexity.
Results/Discussion
Review of Previous Knowledge of Prenylated Proteins
In total, we have collected a list of at least 113 individual
proteins experimentally veriﬁed to be prenylated that are
part of 41 ‘‘KNOWN’’ clusters, and similarity to these justiﬁes
the annotation as ‘‘LIKELY’’ for another 106 clusters in
PRENbase. Thus, a major strength of this work is the
complete proteomic view of prenylation with an added
evolutionary perspective. For example, by querying PRE-
Nbase for families with conserved prenylation motif in
mammals, insects, nematodes, fungi, and plants, we derive a
core set of only three clusters of already known prenylated
proteins. These are the Rab, the Rho/Rac, and the DnaJ-like
heat shock chaperone families which, therefore, could be
postulated as being the oldest examples of prenylated
proteins due to their most widespread taxonomic distribu-
tion. When weakening the conservation requirements and
‘‘only’’ considering conservation in mammals, insects, and
nematodes, several other families join this list of presumably
important prenylated proteins. These are (in the order of the
evOluation ranking): the Ras/Ral/Rap family, the Lamin B
cluster (linking also more generally coiled coil proteins), a
cluster of mixed serine/threonine kinases, geranylgeranylated
G gamma subunits, protein tyrosine phosphatase IVA,
protein phosphatase 1 regulatory subunit 16 (in cluster with
other Ankyrin domain containing proteins), as well as
phosphorylase B kinase aþb subunits. Although spread over
multiple clusters due to their sequence diversity, fungal
mating factors/pheromones compose another large function-
ally related group of prenylated proteins.
In contrast to the examples above where the prenylation
site is highly conserved among various taxa, there are many
cases where the predicted prenylation is speciﬁc to taxo-
nomic lineages or even single species. Nevertheless, this
posttranslational modiﬁcation can be an important require-
ment for function of the respective proteins. Therefore, the
smaller clusters that can be found in PRENbase also merit
deeper investigation.
‘‘The Mother of Ras’’
It is no surprise that the small GTPase families, well-known
for their prenylation, top the evolutionary ranked lists in
Figure 5. Altered Prenylation under FT Inhibition
doi:10.1371/journal.pcbi.0030066.g005
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PRENbasePRENbase. Apparently, multiple duplication events of com-
mon prenylated ancestor genes led to the numerous
paralogous proteins in the Ras superfamily of small GTPases,
resulting in the observed phylogeny of function [26,27].
Although the historical research focus [26] is clearly on the
Ras subfamily due to the oncogenic potential of its most
famous members H-Ras and K-Ras, the evolutionary history
paints a different picture of importance of the Ras/Rap, Rho/
Rac, and Rab families. The Rab family [27] is not only the
most populated one in PRENbase (followed by the Rho/Rac
subfamily), but it also has a much wider taxonomic
distribution. In fact, there are no Ras proteins in plants,
while there are several different Rabs and some Rac
homologues spread in the plant kingdom [28]. Although
highly speculative and by no means unambiguously conclu-
sive, one can attempt to narrow down the candidates for
closest living relatives of the common ancestor of Ras
GTPases by searching for the taxonomically most conserved
individual Ras-related proteins. In HumanPRENbase, the
respective hits are (in decreasing order of the phylogeny-
based ranking): Rab1B, Rab7, Rac1, and Rab6A. So the
‘‘mother of Ras’’ would have been more likely to be related
to Rab or Rac proteins nowadays. Since Rab proteins are
typically dually geranylgeranylated by the type II prenyl-
transferase GGT2 and both Ras and Rac proteins are
speciﬁcally processed by type I prenyltransferases FT and
GGT1, the similarity of substrate characteristics would point
to a closer relationship of Rac to Ras, rather than to Rab
proteins. In agreement with the co-clustering of Ras and Rac
proteins in phylogenetic tree analyses, including other Rab
and more distantly related GTPases, Ras proteins appear to
have emerged from a common ancestor shared with the Rho/
Rac family.
The Anonymous ‘‘Known’’ Group of Plant Copper
Chaperones
In our predictions for prenylated protein families, we ﬁnd
a large group of 88 homologous plant proteins that are
annotated to be metal-binding copper chaperones spread
over 21 clusters. Surprisingly, the mainstream prenylation-
related publications have not mentioned these proteins as
prenylated, so far. A thorough search of the literature,
however, reveals that a previous work has already shown
prenylation for three of these proteins (all in soybean) [29].
Therefore, the corresponding clusters of related proteins
appear in PRENbase annotated as ‘‘KNOWN’’ or ‘‘LIKELY,’’
respectively. Functional characterization of this protein
family appears scarce, and given the large number of
members and the additional information of a conserved
prenylation motif, their likely importance should be subject
to further investigations.
Predictions with New Functional Context for Prenylation
Our approach identiﬁes 979 sequences in 114 clusters that
do not share similarity with already known prenylated
proteins and whose predicted prenylation, therefore, would
expand the possible functional repertoire of prenylated
proteins in cells. Surprisingly, we ﬁnd several proteins that
are related to ubiquitin-mediated protein degradation.
One of these groups comprises some ubiquitin-like
proteins. In particular, UBL3 and its prenylation motif are
not only conserved in organisms from mammals to insects
and worms but, apparently, also in some fungi and plants.
Fitting into the related functional context of ubiquitin-
mediated degradation, it is also interesting to observe
predicted prenylation for several ubiquitin hydrolases. For
example, ubiquitin speciﬁc protease 32 is conserved in
mammals, pufferﬁsh, and insects with a domain architecture
of an N-terminal EF-hand domain, a central DUF1055
domain, followed by a C-terminal ubiquitin hydrolase domain
which ﬁnally precedes the conserved prenylation motif.
Furthermore, we predict several fungal proteins that have a
carboxy-terminal ubiquitin hydrolase domain in addition to a
prenylation motif. Interestingly, there also exists an E2
ubiquitin-conjugating enzyme with conserved prenylation
motif in Arabidopsis and rice.
The connection of prenylation and protein degradation
continues with the prediction of a prenylation site in F-box
and leucine-rich repeat proteins, with FBL2 being conserved
in organisms from mammals to insects, worms, and fungi.
These proteins typically serve as adaptors targeting substrate
proteins of SCF (skip-cullin-F-box) and analogous degrada-
tion complexes [30].
Besides proteins with already known functions, a conserved
prenylation motif is also valuable information for proteins
with domains of unknown functions. Most prominently in our
list, proteins containing a DUF544 domain appear conserved
in organisms from mammals to worms, plants, and fungi. In
another cluster, integral membrane proteins from mammals,
insects, and worms share a DUF1339 domain together with
the prenylation motif.
Selection and Experimental Verification of Human FTI
Targets
The selection of candidates for experimental veriﬁcation
focuses on predictions related to possible human target
proteins for FTIs, because of the implications for important
upcoming cancer therapeutics [25]. Figure 5 depicts the
different types of prenylation substrates distinguished by
their enzyme preference, which determines the effectiveness
of FT inhibition. While H-Ras has long been seen as a primary
target for FTIs, it has become clear that other proteins are
affected as well, and the hunt is on for these elusive FTI
targets [17].
The experimental veriﬁcation of prenylation predictions
follows a new, recently described methodology [18] based on
fast scanning of the incorporation of
3H-labelled prenyl
precursors with a thin layer chromatography (TLC) analyzer.
Details are given in the Materials and Methods section.
Conceptually, we test the site of prenylation by comparing
the incorporation of
3H-labelled mevalonate (general prenyl
anchor precursor) in the wild-type protein and a mutant
protein where the predicted prenylated cysteine is mutated
to alanine (Figures 6–9, lanes 1 and 2). The type of prenyl
anchor preferentially attached to the target proteins in vitro
is tested by comparing the incorporation of
3H-labelled
farnesylpyrophosphate (farnesyl anchor precursor) and ger-
anylgeranylpyrophosphate (geranylgeranyl anchor precur-
sor), respectively (Figures 6–9, lanes 3 and 4). Furthermore,
we investigate the role of prenylation for in vivo localization
of GFP-tagged target proteins (Figure 10). Besides the wild-
type and cysteine-mutant protein, we also analyze the effect
of farnesyltransferase and geranylgeranyltransferase inhib-
itors on localization of the wild-type protein. From a true FTI
PLoS Computational Biology | www.ploscompbiol.org April 2007 | Volume 3 | Issue 4 | e66 0640
PRENbasetarget (pF) we expect the same mislocalisation phenotype
with cysteine mutation and under FT inhibition, but no
phenotype with GGT inhibitor (Figure 10A).
Table 2 shows the predicted human FTI targets (pFs as
deﬁned in Figure 5), top-ranked by evOluation score, and
with numerical and taxonomy statistics of the cluster of
orthologues. Several well-known prenylated proteins are
among the top ten on the list. NAP1-like 1 (ﬁrst) has recently
been shown to be farnesylated [31]. H-Ras (second) is the
classically known FTI target [7]. Also, prenylation of
Figure 7. Western Blots and TLC Scanning Results for FLJ32421 (BROFTI) with Radioactive Prenyl Anchor Precursors
Western blot and corresponding scans from TLC linear analyzer of wild-type GST-FLJ32421-fusion protein translated with [
3H]mevalonic acid (lane 1),
GST-FLJ32421 C408A with [
3H]mevalonic acid (lane 2), GST-FLJ32421 with [
3H]FPP (lane 3) and GST-FLJ32421 with [
3H]GGPP (lane 4). There is significant
incorporation of a product of mevalonic acid as well as FPP, while incorporation of GGPP is close to the detection limit, suggesting that FLJ32421
(BROFTI) is primarily a farnesylation target.
doi:10.1371/journal.pcbi.0030066.g007
Figure 6. Western Blots and TLC Scanning Results for Rab28 with Radioactive Prenyl Anchor Precursors
Western blot and corresponding scans from TLC linear analyzer of wild-type GST-Rab28-fusion protein translated with [
3H]mevalonic acid (lane 1), GST-
Rab28 C218A with [
3H]mevalonic acid (lane 2), GST-Rab28 with [
3H]FPP (lane 3), and GST-Rab28 with [
3H]GGPP (lane 4). There is significant incorporation
of a product of mevalonic acid as well as FPP, while incorporation of GGPP is not detectable, suggesting that Rab28 is primarily a farnesylation target.
doi:10.1371/journal.pcbi.0030066.g006
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PRENbaseFigure 8. Western Blots and TLC Scanning Results for a 15 Amino Acid C-terminal Fragment of Prickle1 with Radioactive Prenyl Anchor Precursors
Western blot and corresponding scans from TLC linear analyzer of wild-type GST-DPrickle1 fusion protein translated with [
3H]mevalonic acid (lane 1),
GST-DPrickle1 C828A with [
3H]mevalonic acid (lane 2), GST-DPrickle1 with [
3H]FPP (lane 3) and GST-DPrickle1 with [
3H]GGPP (lane 4). There is significant
incorporation of a product of mevalonic acid as well as FPP, while incorporation of GGPP is lower despite a higher total amount of protein in the latter
case, suggesting that Prickle1 is primarily a farnesylation target.
doi:10.1371/journal.pcbi.0030066.g008
Figure 9. Western Blots and TLC Scanning Results for a 15 Amino Acid C-terminal Fragment of Prickle2 with Radioactive Prenyl Anchor Precursors
Western blot and corresponding scans from TLC linear analyzer of wild-type GST-DPrickle2-fusion protein translated with [
3H]mevalonic acid (lane 1),
GST-DPrickle2 C842A with [
3H]mevalonic acid (lane 2), GST-DPrickle2 with [
3H]FPP (lane 3), and GST-DPrickle2 with [
3H]GGPP (lane 4). There is significant
incorporation of a product of mevalonic acid as well as FPP, while incorporation of GGPP is lower despite a higher total amount of protein, suggesting
that Prickle2 is primarily a farnesylation target.
doi:10.1371/journal.pcbi.0030066.g009
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PRENbasephosphorylase kinase b (fourth, [32]), Dexras1 (ﬁfth, [33]),
DnaJ/Hsp40 homologues (seventh, [34]), and certain trans-
ducins (tenth, [35]) is well established.
The selective preference of RasD2 (eighth) for farnesyl
anchors has been unambiguously shown in our previous work
[18]. Direct experimental evidence for the prenylation of
Prickle1 (third), the BRO1-domain containing cluster (sixth),
Prickle2 (ninth), as well as for another important protein, the
Rab28 short isoform (12th), is provided here (see paragraph
below). Thus, the experimental veriﬁcation of the prenylation
status of the top clusters is completed with this work.
In humans, Rab28 exists in at least two isoforms, differing
in an insertion at the C-terminus. They are distantly related
to the Rab proteins (;30% sequence identity), which are
important in vesicle fusion and targeting. While the short
isoform is expressed in most tissues, the long isoform is
predominately found in testis [36]. As the enzymological tests
in vitro show (Figure 6), Rab28 (motif: -CAVQ) can be
prenylated exclusively by FT. This conclusion is supported
also by in vivo cell culture studies (as well as for Prickle2 and
FLJ32421/BROFTI; see Figure 10).
The in vitro experimental study provides direct evidence
that FLJ32421 (motif: -CYIS), a hypothetical human protein,
is a preferential farnesylation target (Figure 7). The protein
contains a BRO1/Rhophilin-like domain that is known to
interact with Rho proteins (which often carry prenyl anchors
themselves [37]), and the lipid anchors could generally serve
to co-localize the binding partners [13]. We suggest the name
BROFTI instead of the generic FLJ32421 in tribute to its
domain architecture and prenyltransferase substrate charac-
teristics.
Prickle1 (motif: -CIIS, Figure 8) and Prickle2 (motif: -CIIS,
Figure 9), the human homologues to the prickle gene of
Drosophila melanogaster [38], are both preferential farnesylation
targets. In ﬂy, the gene product is important for establishing
planar cell polarity [39,40]. Similar functions in cell polarity
have been demonstrated in frog (Xenopus laevis) [41], zebraﬁsh
(Danio rerio) [42], and ascidians (Cioni savignyi) [43], indicating
that the function in human might also be in the localization
of the planar cell polarity proteins Frizzled and Dishevelled.
The CaaX box in zebraﬁsh Prickle was already shown to be
important for localization of the protein [42].
While we have tested the prenylation status of evolu-
tionarily widely conserved, high-ranking examples in our list,
there are in total 128 human proteins that serve as predicted
FTI targets. The full list is available online at (http://mendel.
imp.ac.at/sat/PrePS/tmp/Hcs2220ce111ct11111111111111cm1
se200st00202222222221r3.html)
Figure 10. Localization of N-terminal GFP Constructs of Rab28, FLJ32421/BROFTI, Prickle2 (507–844), and RhoA63L in HeLa Cells
HeLa cells were analysed by fluorescence microscopy after transfection with the following constructs: inserts 1, 3, and 4—GFP-Rab28; insert 2—GFP-
Rab28 C218A; inserts 5, 7, and 8—GFP-FLJ32421; insert 6—GFP-FLJ32421 C408A; inserts 9, 11, and 12—Prickle2; insert 10—GFP-Prickle2 C841A; inserts
13, 15, and 16—GFP-RhoA63L (as positive control for a geranylgeranylated target); insert 14—GFP-RhoA63L C190S. The GFP-RhoA plasmids were kindly
provided by Channing J. Der (University of North Carolina Chapel Hill, Chapel Hill, North Carolina, United States). Nuclei were co-stained with DAPI (blue
color).
(A) GFP-Rab28, GFP-FLJ32421, and GFP-Prickle2 are membrane-localized with (4, 8, 12) or without (1, 5, 9) GGTI-298 treatment. Mutation of the Cys in
the CaaX box (2, 6, 10) or treatment with FTI-277 (3, 7, 11) cause mislocalization and accumulation of the fusion proteins in the nucleus.
(B) GFP-RhoA is membrane-localized with (15) or without (13) FTI-277 treatment. Mutation of the Cys in the CaaX box (14) or treatment with GGTI-298
(16) cause mislocalization and accumulation of RhoA in the nucleus.
doi:10.1371/journal.pcbi.0030066.g010
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PRENbaseDual FT/GGT1 Targets Unaffected by FT Inhibition
As opposed to pFs, pFGGs are classiﬁed due to their ability
to be prenylated by either FT or GGT1 (Figure 5). These
pFGGs include (1) proteins with motifs ending in Leucine
that are better GGT1 than FT substrates, as well as (2)
proteins that are normally farnesylated in the cell (better FT
substrates), but can be alternatively prenylated by GGT1 if FT
is inhibited. Table 3 lists the top 15 of the latter group.
Among these are oncogenic proteins such as K-Ras and N-
Ras, with the severe result that FTI inhibitors are ineffective
against associated cancers.
New Viral Proteins Processed by Eukaryotic Host Enzymes
Previously, the only known examples of prenylation of viral
proteins by the eukaryotic host were the Hepatitis Delta large
antigen and viral variants of H-Ras and K-Ras, as well as the
US2 tegument protein of bovine Herpes viruses.
Surprisingly, our search reveals two candidate proteins
from Mimivirus, a giant virus in amoebae that might be a
pneumonia-associated human pathogen [44,45]. The ﬁrst
predicted prenylated Mimivirus protein is most closely
related to Rab GTPases, while the second is a DnaJ-like
molecular chaperone. This particularly large DNA virus is
known for its extraordinary gene content normally absent in
other viruses [46]. Since there is no similarity to the
prenylating enzymes in the Mimivirus genome, the predicted
prenylation motifs would only be able to receive a lipid
anchor by eukaryotic host enzymes. In light of the fact that
several Mimivirus proteins originate from horizontal gene
transfer from eukaryotes [47], it is interesting to note that the
Rab-like protein is most similar to Rabs found in three
different Alveolata species, while the DnaJ-like protein has its
closest homologues in Trypanosomes. If, indeed, the preny-
lation motif would have remained functional and been
processed by eukaryotic host enzymes, FTI inhibitors could
eventually affect the lipid modiﬁcation of the DnaJ-like
protein whose -CAQQ motif cannot be prenylated by
enzymes other than farnesyltransferase.
While there are several other predictions of prenylation
motifs in viral proteins (170 sequences in 46 clusters), it is
difﬁcult to estimate the likelihood of their functionality,
given the requirement that eukaryotic host enzymes be
available. Hence, we are more conﬁdent in predicted
prenylation motifs in proteins that are at least homologous
to proteins with known prenylation in Eukaryotes. As an
additional example to the above Mimivirus proteins, we ﬁnd
an ankyrin domain–containing protein with FT-speciﬁc
prenylation motif conserved in canarypox and fowlpox virus.
Importance of Specific Prenyl Anchor Length and
Evolutionary Exchangeability
Farnesyl (C15) and geranylgeranyl (C20) anchors differ in
lengthbyoneisopreneunit(C5).However,thisdifferencedoes
notseemtomatterforsomeproteins,suchastheyeasta-factor
mating pheromone [48] and RhoA [49]. On the contrary,
importance of the speciﬁc prenyl anchor length has been
shown,atleast,forGgamma1and2[50],rhodopsinkinase[51],
H-Ras [52,53], R-Ras [53], and RhoB [54]. Besides the change in
hydrophobicityandalteredmembraneafﬁnity,thecauseofthe
length dependency might lie in speciﬁc interactions with
prenyl-binding domains of other proteins [6].
In PRENbase, we observe that protein families differ in the
evolutionary exchangeability of farnesyl and geranylgeranyl
anchors. While there are several pFGG families where both
anchor types are predicted to occur, there are a few pF-only
families where farnesyl anchors appear to be the strongly
preferred lipid type. From the above list of known examples
for length dependency, we ﬁnd that only G gamma 1 and 2
have a purely conserved farnesyl preference. While for
rhodopsin kinase only the chicken orthologue switched to
geranylgeranyl, there are several lower eukaryotes with an H-
Ras orthologue ending in a geranylgeranylation motif. R-Ras
and RhoB end with a -CXXL motif that by itself already can
be substrate of either FT or GGT1.
At the same time, the a-factor mating pheromones, where
anchor length should be less important, also appear in pF-
only families, which, however, could be due to the conﬁne-
ment of clustering together only very closely related species
lacking evolutionary time to diverge. The same probably
applies to the many almost identical large subunits of
Hepatitis delta virus, which are clustered into a pF-only
family. On the other hand, the FT restriction also represents a
possible vulnerability to FT inhibitors.
Given the above listed ambiguities, one cannot conclude
with certainty whether a speciﬁc prenyl anchor length is
important for a protein family based on the evolutionary
variability of substrate preferences. However, in a taxonomi-
cally widely conserved family, a clear preference for farnesy-
lation could still indicate a length dependency and,
consequently, a requirement of farnesyl for speciﬁc protein–
protein interactions. In HumanPRENbase, besides the above
mentioned G gamma 1 and 2, the following families fall under
these criteria: nucleosome assembly protein 1-like 1, prickle-
like1,phosphorylase kinase b,FLJ32421/BROFTI, RasD2/Rhes,
Table 3. High-Ranked FT Substrates Predicted To Be Unaffected
by FT Inhibition
ClustID Protein Name Motif
15718763 c-K-ras2 protein isoform a ...EKTPGCVKIKKCIIM
15718761 c-K-ras2 protein isoform b ...GKKKKKKSKTKCVIM
5730120 SNARE protein Ykt6 ...FYKTAKRQNSCCAIM
42490908 Rheb: Ras homolog enriched in brain ...MDGAASQGKSSCSVM
15126742 Lamin B1 ...QQGTPRASNRSCAIM
4456614 PALM: Paralemmin ...DLDMKKHRCKCCSIM
7657514 Rho6/Rnd1: Rho-related GTP-
binding protein
...SSTFKKEKAKSCSIM
4506339 Peroxisomal biogenesis factor Pex19 ...LSGPPGASGEQCLIM
3417289 C16orf45 homolog, unknown function ...ALIKDCCGATQCNIM
3406430 hPRL-3 protein tyrosine phosphatase ...RFKDPHTHKTRCCVM
21553323 DiRas1/Rig: small GTP-binding tumor
suppressor 1
...KQKRTDRVKGKCTLM
40788968 Rho-related BTB domain-containing
protein KIAA0878
...YRKYIHSRKCRCLVM
21748630 Protein phosphatase 1, regulatory
(inhibitor) subunit 16A
...AVEAPVERRPCCLLM
37595069 N-Ras: neuroblastoma Ras oncogene
homolog
...DDGTQGCMGLPCVVM
39653934 Lamin A/progerin ...ASGSGAQSPQNCSIM
ClustID, cluster IDs from HumanPRENbase, but also corresponding to GenBank GI
numbers.
Positively charged residues in the motif are colored blue. The full list is online.
doi:10.1371/journal.pcbi.0030066.t003
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PRENbaseRhoH,Rab28longisoform,RhoQ,EHdomainbindingprotein
1, DnaJ-homolog A4, 72kDa inositol polyphosphate-5-phos-
phatase E, and WDþtetratricopeptide repeats protein 1.
Conclusions
PRENbase provides (1) a review of previous knowledge of
known and likely prenylated proteins resulting in the
rediscovery of the large group of prenylated metal-binding
chaperones in plants; (2) target lists for experimental
validation of newly predicted prenylation are ranked by
evolutionary conservation, which leads to the notion that
several proteins involved in ubiquitin-mediated protein
degradation could be prenylated; (3) lists of possible targets
for FT inhibition (human proteins that are unique substrates
of FT and not GGT1 or GGT2) with the experimental
evidence for Prickle1, Prickle2, the BRO1-domain-containing
FLJ32421 (termed BROFTI), and Rab28 (short isoform); (4)
lists of dual FT/GGT substrates that are essentially not
affected by FT inhibition or that can receive an altered
anchor type under FT inhibition; (5) a list of viral proteins
possibly processed by eukaryotic host enzymes, most notably
two proteins from Mimivirus; as well as (6) examples of the
importance of speciﬁc farnesyl anchor length (clusters that
only include FT but not GGT1 or GGT2 substrates) that could
be indicative of involvement in protein–protein interactions.
Materials and Methods
PRENbase family clustering procedure. In MYRbase, sequences
with higher than 40% sequence identity have been clustered into
protein families. This rather conservative threshold is reasonable to
infer similarity of biological function [55–57] with conﬁdence, but
frequently leads to spreading protein families with many remotely
similar members and from phylogenetically distant taxa over several
clusters. In the case of PRENbase, we applied the MCL procedure to
unite many of these clusters [22] and to facilitate a more
comprehensive phylogenetic comparison. The use of BLAST [21]
allows ﬁnding more remote homologues, but simple single linkage
clustering based merely on signiﬁcant BLAST similarity cannot
account for the multidomain modular architecture of proteins. For
example, frequently occurring regulatory domains (such as SH3) can
appear in different contexts with other domains. Therefore, proteins
with different functions would be clustered together according to
their similarity in such a single overlapping domain hit. These
problems seem to have been largely overcome by the MCL algorithm
[22] that allows for a certain ﬂexibility of intercluster BLAST
connections that are weaker than respective average intracluster
links. More precisely, the MCL method understands sequences as
nodes in a graph with edges between nodes weighted by the negative
logarithm of the BLAST E-value of the two sequences (the average of
backward and forward searches); hence, their sequence similarity.
The graph is transformed into a matrix with edge weights being
normalized to probabilities of walking between nodes. When
simulating random walks within the graph, walks within clusters are
much more likely than walks between clusters. Through iterative
expansion and inﬂation of the matrix (until the matrix essentially
remains unaltered by further iterations), the links within clusters are
strengthened and intercluster connections downweighted.
To cluster predicted proteins into their natural families inde-
pendent of the existence/prediction of a lipid anchor, we have
executed BLAST searches (E-value 0.005) starting with the 5,410
predicted proteins against the same complete database from which
the predictions were derived (NCBI’s NR with 2,179,151 entries, based
on GenBank/GenPept version 144). Using the measured BLAST
similarity as input for MCL [22], with the inﬂation parameter I set to
5.0 (for ﬁne-grained clusterings, best precision in a benchmark of
clustering SCOP families [22]), we obtain 1,024 clusters. For
comparison, single linkage clustering of the 5410 proteins at an E-
value threshold of 0.005 would result in 615 clusters, merging several
clusters compared with the MCL clustering.
HumanPRENbase orthologue clustering. We ﬁrst generated a list
of human proteins that are predicted to be prenylated by at least one
of the three enzymes FT, GGT1, and GGT2 by running PrePS over
NCBI’s NR. Then, we determined the orthologues in other organisms
with the condition of best reciprocal BLAST hits. The algorithm
employed here follows in the steps of earlier methods to detect
orthology and paralogy relationships [58,59], employing the deﬁni-
tion of orthologues and in-paralogues as in [60]. This scheme,
however, is not straightforward due to several problems. First, the
reciprocal similarity search started with the nonhuman organism
might ﬁnd an isoform or in-paralogue (duplication has occurred after
the last speciation event) of the initial human query as best hit. We
have found that a threshold of greater than or equal to 98% identity
(within the aligned segments) is a reasonable threshold with which to
classify isoforms. In-paralogues were identiﬁed as human proteins
that occur as BLAST hits with an E-value smaller than E-50 (this
threshold is set to limit the number of noninformative reciprocal
BLASTs) and that ﬁnd the initial query or ﬁnd one of its known
isoforms in a reciprocal BLAST before proteins of any nonhuman
species. Finally, we deﬁne orthologues as proteins that are the best
hits of their species to a human query protein and that in a back-
BLAST ﬁnd either the initial query or its isoforms or in-paralogues as
best human hit.
Construct production and cloning. We generated plasmids con-
taining GST and pEGFP fusions of all genes studied in this work. The
cDNAs of Rab28 short isoform and FLJ32421/BROFTI were cloned
into the pGEX5X1-vector, thereby creating N-terminal GST-fusion
proteins. Since the cDNAs received for Prickle1 and Prickle2 did not
match or only partially matched the desired sequence, we used
oligonucleotides representing the last 15 residues at the C-terminus
instead. The Stratagene QuikChange XL Site-Directed Mutagenesis
Kit was used to introduce a cysteine-to-alanine mutation in the CaaX
motif. Since this residue is the site of covalent thioether linkage of the
isoprenoid modiﬁcation, the ability to become modiﬁed should be
abolished. Both wild-type and mutant cDNA of Rab28 short isoform
and FLJ32421/BROFTI were also cloned into the pEGFP C2 vector.
For Prickle2, we used a C-terminal fragment representing the last 338
residues at the C-terminus, which is the longest matching sequence
we had available. The N-terminal GFP-fusion proteins were used to
investigate the subcellular localization in transiently transfected
HeLa cells. No GFP-construct of Prickle1 was cloned, since the
localization of the last 15 amino acids would not have been
representative at all.
In vitro prenylation assay. The cDNA of the GST fusion proteins
wasampliﬁed by PCR and transcribed and translated in vitrousing the
Promega TNT Quick Coupled Transcription/Translation Kit in the
presence of the radioactive label of choice (typically, 20 lCi
[
3H]mevalonic acid, 10 lCi [
3H]FPP, or [
3H]GGPP, all purchased from
American Radiolabeled Chemicals, http://www.arc-inc.com). The tar-
get protein was puriﬁed using glutathione sepharose 4B-beads (75%
slurry, from Amersham Biosciences, http://www.gelifesciences.com),
precipitated with ice-cold acetone and resuspended in sample buffer.
After SDS-PAGE and transfer to a nitrocellulose membrane by
electroblotting, the incorporated label was detected using a Berthold
TLC linear analyzer LB 282. The protein yield was detected by
standard Western blotting techniques (primary antibody: anti-GST-
antibody from rabbit, 1:5,000; secondary antibody: ECL Anti-rabbit
IgG, Horseradish peroxidase linked whole antibody from donkey
purchased from Amersham Biosciences, 1:10.000; ECL plus Western
Blotting Detection Kit solution, Hyperﬁlm ECL from Amersham
Biosciences).
Determination of intracellular localization. HeLa cells were trans-
fected with the GFP-expression vector constructs for Rab28 short
isoform, FLJ32421/BROFTI and Prickle2 using Lipofectamine and
Plus Reagent in serum-free medium (Life Technologies, http://www.
invitrogen.com). The cells were grown to sufﬁcient density, ﬁxed,
permeabilized, washed, and mounted in vectashield (Vector Labo-
ratories, http://www.vectorlabs.com). Localization of the fusion
proteins was investigated by ﬂuorescence microscopy. The effect of
farnesylation and geranylgeranylation inhibitors was assessed by
treatment of the cells with FTI-277 (10 lM) or GGTI-298 (5 lM)
(Sigma, http://www.sigmaaldrich.com). All experimental procedures
were performed as previously described [18].
Supporting Information
Accession Numbers
Accession numbers (IMAGE clone ID) of cDNA clones from the RZPD
clone libraries (http://www.rzpd.de/products/clones) used in this paper
are: FLJ32421/BROFTI (IMAGp961F02139Q2), Prickle1
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PRENbase(IMAGp998C0210744Q1), Prickle2 (IMAGp686N1787Q2), and Rab28
short isoform (IMAGp686F1021Q2).
Accession numbers from GenBank (http://www.ncbi.nlm.nih.gov/
Genbank) of mRNA corresponding to the cDNA clones used in this
paper are: Rab28 short isoform (NM_001017979), Prickle1
(NM_153026), Prickle2 (NM_198859), and FLJ32421/BROFTI
(NM_144695).
Accession numbers of clusters from PRENbase (http://mendel.imp.
ac.at/sat/PrePS/PRENbase) mentioned in this paper are: a-factor
mating pheromones (6324184), mammalian, insect and nematode
UBL3s (22137475), fungal and plant UBL3s (50912815), ubiquitin
speciﬁc protease 32 (13560797), fungal ubiquitin hydrolases
(50426781) and (40744684), E2 ubiquitin-conjugating enzyme from
Arabidopsis and rice (50918253), F-box and leucine-rich repeat
proteins (47218849), proteins containing a DUF544 domain
(35193062 and 40740499), integral membrane proteins from mam-
mals, insects, and worms sharing a DUF1339 domain (20521916).
Accession numbers of clusters from HumanPRENbase (http://
mendel.imp.ac.at/sat/PrePS/HumanPRENbase/) mentioned in this
paper are: nucleosome assembly protein 1-like 1 (21327708),
prickle-like 1 (23308518), phosphorylase kinase b (4505783),
FLJ32421/BROFTI (55665085), RasD2/Rhes (4092830), RhoH
(4757770), Rab28 long isoform (4758994), RhoQ (51460469), EH
domain binding protein 1 (45501001), DnaJ-homolog A4 (21758015),
72kDa inositol polyphosphate-5-phosphatase E (38327539), WDþte-
tratricopeptide repeats protein 1 (41018470), G gamma 1 (2695592),
G gamma 2 (14589849), rhodopsin kinase (4506529), H-Ras (4885425),
R-Ras (5454028), and RhoB (37718739).
Accession numbers (GI numbers) from GenBank (http://www.ncbi.
nlm.nih.gov/Genbank) of proteins mentioned in this paper are:
ankyrin-repeat containing proteins from canarypox (40555979) and
fowlpox virus (41023315), Mimivirus Rab-like protein (55819093), and
Mimivirus DnaJ-like molecular chaperone (55819138).
Additional accession numbers of clusters from HumanPRENbase
(http://mendel.imp.ac.at/sat/PrePS/HumanPRENbase/) can be found in
Tables 2 and 3.
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